NO20042139L - Fremgangsmate for behandling av hyperaktiv blaere - Google Patents

Fremgangsmate for behandling av hyperaktiv blaere

Info

Publication number
NO20042139L
NO20042139L NO20042139A NO20042139A NO20042139L NO 20042139 L NO20042139 L NO 20042139L NO 20042139 A NO20042139 A NO 20042139A NO 20042139 A NO20042139 A NO 20042139A NO 20042139 L NO20042139 L NO 20042139L
Authority
NO
Norway
Prior art keywords
hyperactive bladder
treating hyperactive
treating
bladder
hyperactive
Prior art date
Application number
NO20042139A
Other languages
English (en)
Norwegian (no)
Inventor
Russel Bialecki
Cathy Dantzman
Keith Herzog
Original Assignee
Astrazeneca Ab Global Ip
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab Global Ip filed Critical Astrazeneca Ab Global Ip
Publication of NO20042139L publication Critical patent/NO20042139L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20042139A 2001-11-02 2004-05-25 Fremgangsmate for behandling av hyperaktiv blaere NO20042139L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0103668A SE0103668D0 (sv) 2001-11-02 2001-11-02 Method for the treatment of overactive blader
PCT/SE2002/001990 WO2003037341A1 (en) 2001-11-02 2002-11-01 Method for the treatment of overactive bladder

Publications (1)

Publication Number Publication Date
NO20042139L true NO20042139L (no) 2004-06-25

Family

ID=20285870

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042139A NO20042139L (no) 2001-11-02 2004-05-25 Fremgangsmate for behandling av hyperaktiv blaere

Country Status (13)

Country Link
US (1) US20040248914A1 (sl)
EP (1) EP1450805A1 (sl)
JP (1) JP2005511561A (sl)
KR (1) KR20050042211A (sl)
CN (1) CN1622806A (sl)
BR (1) BR0213776A (sl)
CA (1) CA2465140A1 (sl)
IL (1) IL161599A0 (sl)
MX (1) MXPA04004071A (sl)
NO (1) NO20042139L (sl)
SE (1) SE0103668D0 (sl)
WO (1) WO2003037341A1 (sl)
ZA (1) ZA200403199B (sl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006121389A1 (en) * 2005-05-10 2006-11-16 Astrazeneca Ab Use of a neurokinin-2 receptor antagonist for treating or preventing detrusor overactivity
US10441620B2 (en) * 2016-09-21 2019-10-15 Wellstrong Biotech Co., Ltd. Method for protection of bladder from damage

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE300218B (sl) * 1960-11-08 1968-04-22 Recip Ab
US5382600A (en) * 1988-01-22 1995-01-17 Pharmacia Aktiebolag 3,3-diphenylpropylamines and pharmaceutical compositions thereof
GB8906166D0 (en) * 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
GB9310713D0 (en) * 1993-05-24 1993-07-07 Zeneca Ltd Aryl substituted heterocycles
GB9317104D0 (en) * 1993-08-17 1993-09-29 Zeneca Ltd Therapeutic heterocycles
US6008223A (en) * 1994-10-27 1999-12-28 Zeneca Limited Therapeutic compounds
GB9505084D0 (en) * 1995-03-14 1995-05-03 Pfizer Ltd Benzamide derivative
GB9922519D0 (en) * 1998-10-07 1999-11-24 Zeneca Ltd Compounds
GB9924141D0 (en) * 1998-10-30 1999-12-15 Zeneca Ltd Treatment of gastric asthma
GB9826941D0 (en) * 1998-12-09 1999-02-03 Zeneca Pharmaceuticals Compounds
GB0015246D0 (en) * 2000-06-22 2000-08-16 Astrazeneca Ab Method for the treatment of urinary incontinence

Also Published As

Publication number Publication date
BR0213776A (pt) 2004-11-09
JP2005511561A (ja) 2005-04-28
MXPA04004071A (es) 2004-09-06
IL161599A0 (en) 2004-09-27
WO2003037341A1 (en) 2003-05-08
CA2465140A1 (en) 2003-05-08
SE0103668D0 (sv) 2001-11-02
US20040248914A1 (en) 2004-12-09
CN1622806A (zh) 2005-06-01
ZA200403199B (en) 2005-02-09
KR20050042211A (ko) 2005-05-06
EP1450805A1 (en) 2004-09-01

Similar Documents

Publication Publication Date Title
NO20030241D0 (no) Fremgangsmåte for behandling av multiple brönnintervaller
NO20025814D0 (no) Fremgangsmåte ved brönnfullföring
NO20042609L (no) Fremgangsmate for identifisering av tumormalrettede enzymer
NO20032172L (no) Fremgangsmåte ved behandling av underjordisk formasjon
NO20030265D0 (no) Fremgangsmåter ved behandling av borebrönner
NO20031082L (no) Fremgangsmåte for behandling av underjordiske formasjoner
NO20032229L (no) Fremgangsmåter for behandling av p38kinase-assosierte tilstander og pyrrolotriazin forbindelser nyttige som kinase inhibitorer
NO20030486D0 (no) Fremgangsmåte ved innkapsling av v¶ske egnet for brönnbehandling
NO20033192L (no) Fremgangsmåte for behandling av dopamin-relaterte dysfunksjoner
NO20024423D0 (no) Fremgangsmåte for hydrobehandling av en hydrokarbontilförsel
NO20043623L (no) Fremgangsmate for fremstilling av papir
NO20014222L (no) Fremgangsmåte for behandling av COPD
NO20033884D0 (no) Fremgangsmåte for påvisning av nukleinsyremolekyler
FI20012446A0 (fi) Menetelmä kartongin jälkikäsittelemiseksi
NO20042139L (no) Fremgangsmate for behandling av hyperaktiv blaere
NO20035690D0 (no) Fremgangsmåte for å öke pH
NO20015162D0 (no) Fremgangsmåte for behandling av nevrodegenerering
DE50206006D1 (de) Verfahren zum Herstellen von Mikroschleifkontakten
FI20000325A0 (fi) Menetelmä rakenteen rasituksen määrittämiseksi
DK1405082T3 (da) Fremgangsmåde til identificering af forbindelser til terapi af hjertekarsystemets ældningsprocesser
NO20030788D0 (no) Fremgangsmåte ved behandling av kjött
FI20011908A0 (fi) Menetelmä vatsasyövän osoittamiseksi
NO20031969D0 (no) Fremgangsmåte ved måling av gjennomströmning ved hjelp av ultralyd
NO20022157D0 (no) Fremgangsmåte for behandling av medikamentavhengighet
NO20022883D0 (no) Fremgangsmåte for behandling av tre